Login to Your Account

Financings Roundup

Positive Interim Review Leads to $50M Financing for Sangart

By Catherine Shaffer
Staff Writer

Tuesday, May 29, 2012
Sangart Inc. added $50 million in additional equity financing through its existing investor, Leucadia National Corp. The funding was made upon exercise of Series G preferred stock warrants held by Leucadia, and brings the total amount raised by the company to $280 million.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription